Cun D - Search Results

1

pH-Sensitive Nano-Complexes Overcome Drug Resistance and Inhibit Metastasis of Breast Cancer by Silencing Akt Expression.

Yin J, Lang T, Cun D, Zheng Z, Huang Y, Yin Q, Yu H, Li Y. Yin J, et al. Among authors: cun d. Theranostics. 2017 Sep 26;7(17):4204-4216. doi: 10.7150/thno.21516. eCollection 2017. Theranostics. 2017. PMID: 29158820 Free PMC article.

2

Erratum: pH-Sensitive Nano-Complexes Overcome Drug Resistance and Inhibit Metastasis of Breast Cancer by Silencing Akt Expression: Erratum.

Yin J, Lang T, Cun D, Zheng Z, Huang Y, Yin Q, Yu H, Li Y. Yin J, et al. Among authors: cun d. Theranostics. 2020 Jan 18;10(5):2399-2400. doi: 10.7150/thno.42847. eCollection 2020. Theranostics. 2020. PMID: 32104510 Free PMC article.

3

Advances in combination therapy of lung cancer: Rationales, delivery technologies and dosage regimens.

Wu L, Leng D, Cun D, Foged C, Yang M. Wu L, et al. Among authors: cun d. J Control Release. 2017 Aug 28;260:78-91. doi: 10.1016/j.jconrel.2017.05.023. Epub 2017 May 17. J Control Release. 2017. PMID: 28527735 Review.

4

Cisplatin-loaded polymeric complex micelles with a modulated drug/copolymer ratio for improved in vivo performance.

Chen Q, Luo L, Xue Y, Han J, Liu Y, Zhang Y, Yin T, Wang L, Cun D, Gou J, He H, Tang X. Chen Q, et al. Among authors: cun d. Acta Biomater. 2019 Jul 1;92:205-218. doi: 10.1016/j.actbio.2019.05.007. Epub 2019 May 6. Acta Biomater. 2019. PMID: 31071475

5

Engineering Transferrin-Decorated Pullulan-Based Prodrug Nanoparticles for Redox Responsive Paclitaxel Delivery to Metastatic Lung Cancer Cells.

Zhao X, Guo H, Bera H, Jiang H, Chen Y, Guo X, Tian X, Cun D, Yang M. Zhao X, et al. Among authors: cun d. ACS Appl Mater Interfaces. 2023 Jan 25;15(3):4441-4457. doi: 10.1021/acsami.2c18422. Epub 2023 Jan 12. ACS Appl Mater Interfaces. 2023. PMID: 36633929

6

Design of high payload PLGA nanoparticles containing melittin/sodium dodecyl sulfate complex by the hydrophobic ion-pairing technique.

Yang L, Cui F, Shi K, Cun D, Wang R. Yang L, et al. Among authors: cun d. Drug Dev Ind Pharm. 2009 Aug;35(8):959-68. doi: 10.1080/03639040902718039. Drug Dev Ind Pharm. 2009. PMID: 19274512

7

Formulation strategies and particle engineering technologies for pulmonary delivery of biopharmaceuticals.

Cun D, Wan F, Yang M. Cun D, et al. Curr Pharm Des. 2015;21(19):2599-610. doi: 10.2174/1381612821666150416100800. Curr Pharm Des. 2015. PMID: 25876915 Review.

8

Poly(lactide-co-glycolide) Nanoparticles Mediate Sustained Gene Silencing and Improved Biocompatibility of siRNA Delivery Systems in Mouse Lungs after Pulmonary Administration.

Wu L, Wu LP, Wu J, Sun J, He Z, Rodríguez-Rodríguez C, Saatchi K, Dailey LA, Häfeli UO, Cun D, Yang M. Wu L, et al. Among authors: cun d. ACS Appl Mater Interfaces. 2021 Jan 27;13(3):3722-3737. doi: 10.1021/acsami.0c21259. Epub 2021 Jan 13. ACS Appl Mater Interfaces. 2021. PMID: 33439616

9

Pulmonary Delivery of Reactive Oxygen Species/Glutathione-Responsive Paclitaxel Dimeric Nanoparticles Improved Therapeutic Indices against Metastatic Lung Cancer.

Tian X, Bera H, Guo X, Xu R, Sun J, He Z, Cun D, Yang M. Tian X, et al. Among authors: cun d. ACS Appl Mater Interfaces. 2021 Dec 8;13(48):56858-56872. doi: 10.1021/acsami.1c16351. Epub 2021 Nov 20. ACS Appl Mater Interfaces. 2021. PMID: 34806372

10

Recent advances in pH/enzyme-responsive polysaccharide-small-molecule drug conjugates as nanotherapeutics.

Abbasi YF, Bera H, Cun D, Yang M. Abbasi YF, et al. Among authors: cun d. Carbohydr Polym. 2023 Jul 15;312:120797. doi: 10.1016/j.carbpol.2023.120797. Epub 2023 Mar 11. Carbohydr Polym. 2023. PMID: 37059536 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

80 results

Search Page